Compare

Axogen, Inc. vs Outset Medical, Inc. vs Iridex Corp vs LivaNova PLC

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAxogen, Inc.
AXGN
Outset Medical, Inc.
OM
Iridex Corp
IRIX
LivaNova PLC
LIVN
Year ended2025-12-312025-12-312026-01-032025-12-31
Revenue$225.21M$119.48M$52.67M$1.39B
Revenue growth (YoY)+20.2%+5.1%+8.2%+10.7%
Gross margin74.3%39.1%36.5%67.7% (computed)
Operating margin-3.5%-55.8%-4.9%14.4%
Net margin-7.0%-68.3%-8.4%-17.5%
Net income-$15.70M-$81.65M-$4.44M-$242.47M
EPS (Diluted)-$0.34-$5.37-$0.26-$4.45
Operating cash flow$812.0K-$46.33M-$2.12M$254.34M
Free cash flow-$2.93M-$47.12M-$2.26M$173.29M
Cash & equivalents$35.55M$35.01M$6.03M$635.55M
Total assets$221.69M$264.50M$29.15M$2.61B
Total liabilities$92.84M$137.54M$24.23M$1.41B
Shareholders' equity$128.85M$126.95M$4.92M$1.20B
Return on year-end equity-12.2%-64.3%-90.1%-20.2%
Shares outstanding47.20M18.17M17.31M54.65M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAxogen, Inc.Outset Medical, Inc.Iridex CorpLivaNova PLC
Latest$225.21M
Ended 2025-12-31
$119.48M
Ended 2025-12-31
$52.67M
Ended 2026-01-03
$1.39B
Ended 2025-12-31
1 year earlier$187.34M
Ended 2024-12-31
$113.69M
Ended 2024-12-31
$48.67M
Ended 2024-12-28
$1.25B
Ended 2024-12-31
2 years earlier$159.01M
Ended 2023-12-31
$130.38M
Ended 2023-12-31
$51.87M
Ended 2023-12-30
$1.15B
Ended 2023-12-31
3 years earlier$138.58M
Ended 2022-12-31
$115.38M
Ended 2022-12-31
$56.97M
Ended 2022-12-31
$1.02B
Ended 2022-12-31
4 years earlier$127.36M
Ended 2021-12-31
$102.60M
Ended 2021-12-31
$53.90M
Ended 2022-01-01
$1.04B
Ended 2021-12-31